Product Images Esomeprazole Magnesium
View Photos of Packaging, Labels & Appearance
- Figure 2: Maintenance of Healing Rates of EE in Adults by Month (Study 177) - esomeprazole fig1
- Figure 3: Maintenance of EE Healing Rates in Adults by Month (Study 178) - esomeprazole fig2
- Figure 4: Percent of Patients Symptom-Free of Heartburn by Day (Study 225) - esomeprazole fig3
- Figure 5: Percent of Patients Symptom-Free of Heartburn by Day (Study 226) - esomeprazole fig4
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (30 Capsules Bottle) - esomeprazole fig5
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (1 x 14) Unit-dose Capsules - esomeprazole fig6
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 40 mg (30 Capsules Bottle) - esomeprazole fig7
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 40 mg (10 x 10) Unit-dose Capsules - esomeprazole fig8
- Chemical Structure - esomeprazole str
Product Label Images
The following 9 images provide visual information about the product associated with Esomeprazole Magnesium NDC 59651-562 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 2: Maintenance of Healing Rates of EE in Adults by Month (Study 177) - esomeprazole fig1
This description is not-available.*
Figure 3: Maintenance of EE Healing Rates in Adults by Month (Study 178) - esomeprazole fig2
This description seems to detail a study or data regarding the effectiveness or maintenance of Esomeprazole Magnesium at different dosage levels. The percentages shown likely indicate the success rate or effectiveness of the medication over a certain period of time. The text also seems to mention a placebo group for comparison. The study appears to span multiple months.*
Figure 4: Percent of Patients Symptom-Free of Heartburn by Day (Study 225) - esomeprazole fig3
This text provides information on a study that compared the efficacy of Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg doses with a Placebo in relation to patient symptom relief. The study appears to have recorded data up to 21 days, with the results showing the percentage of patients who were symptom-free at different points in time (7, 14, 21 days). This numerical data can help evaluate the effectiveness of these treatments in managing symptoms.*
Figure 5: Percent of Patients Symptom-Free of Heartburn by Day (Study 226) - esomeprazole fig4
This information seems to be about the results of a study or trial comparing the efficacy of Esomeprazole Magnesium Delayed-Release Capsules in 40 mg and 20 mg doses with a placebo in terms of alleviating symptoms in patients. According to the data provided, 100% of patients taking Esomeprazole Magnesium Delayed-Release Capsules at either dose were symptom-free, while the placebo had a lower effectiveness rate.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (30 Capsules Bottle) - esomeprazole fig5
This text contains information about NDC 59651-561-30, which is a medication called Esomeprazole Magnesium Delayed-Release Capsules USP. Each capsule contains esomeprazole magnesium trihydrate USP equivalent to 20 mg of esomeprazole. The usual adult dosage instructions can be found in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) and the container should be kept tightly closed. It is distributed by Aurobindo Pharma USA, Inc. and made in India.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 20 mg (1 x 14) Unit-dose Capsules - esomeprazole fig6
This text is a description of Esomeprazole Magnesium Delayed-Release Capsules USP, containing 20 mg of Esomeprazole magnesium. It gives information on the dosage, storage conditions, and the need for a child-resistant container. The text also provides details for the pharmacist regarding dispensing and mentions the manufacturer's address.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 40 mg (30 Capsules Bottle) - esomeprazole fig7
This is a description for Esomeprazole Magnesium Delayed-Release Capsules USP by Aurobindo Pharma USA, Inc. Each capsule contains esomeprazole 40 mg. The usual adult dosage information can be found in the package insert. The medication guide should be dispensed separately to each patient. The capsules are stored at 20° to 25°C and the manufacturing details include the address of Aurobindo Pharma USA, Inc. in East Windsor, NJ.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 40 mg (10 x 10) Unit-dose Capsules - esomeprazole fig8
This is a description of a pharmaceutical product. It is a package of Esomeprazole Magnesium Delayed-Release Capsules USP, containing 100 unit-dose capsules. Each capsule contains Esomeprazole magnesium trinydrate USP equivalent to esomeprazole 40 mg. The recommended adult dosage should be consulted from the package insert. The storage conditions are specified to maintain efficacy. The text also mentions the importance of keeping the container tightly closed and indicates that the unit-dose package is not child-resistant. Pharmacists are instructed to dispense a Medication Guide to each patient. The product is manufactured by Aurobindo Pharma USA and the code provided is TS/DRUGS2212008.*
Chemical Structure - esomeprazole str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
